help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamrah, P.
Right arrow Articles by Dana, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamrah, P.
Right arrow Articles by Dana, M. R.
(American Journal of Pathology. 2003;163:57-68.)
© 2003 American Society for Investigative Pathology

Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells

Pedram Hamrah, Lu Chen, Qiang Zhang and M. Reza Dana

From the Laboratory of Immunology, Schepens Eye Research Institute and the Massachusetts Eye and Ear Infirmary and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts

Vascular endothelial growth factor-3 (VEGFR-3) plays a critical role in embryonic cardiovascular development and is thought to be expressed exclusively on the lymphatic endothelium, high endothelial venules, and rarely on adult vascular endothelium. Recent evidence also suggests expression of VEGFR-3 on some tumor-associated macrophages. We have studied the expression of VEGFR-3, its ligand VEGF-C and the co-receptor neuropilin-2, in normal and inflamed corneas and characterized the phenotype and distribution of VEGFR-3+ cells. Our data demonstrate, for the first time, the expression of VEGFR-3 on corneal dendritic cells (DC) and its up-regulation in inflammation. VEGFR-3+ DC are CD11c+CD45+CD11b+, and are mostly major histocompatibility (MHC) class II-CD80-CD86-, indicating immature DC of a monocytic lineage. During inflammation, there is rapid increase in the number of VEGFR-3+ DC in the cornea associated with heightened membranous expression as compared to a mostly intracellular expression in uninflamed tissue. VEGFR-3+ DC in normal corneas are VEGF-C-neuropilin-2-, but express VEGF-C in inflammation. Interestingly, similar cells are absent both in the normal and inflamed skin. These data demonstrate, for the first time, the expression of VEGFR-3 and VEGF-C on tissue DC, which implicate a novel potential relationship between lymphangiogenesis and leukocyte trafficking in the eye.





This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q. Zhang, R. Guo, Y. Lu, L. Zhao, Q. Zhou, E. M. Schwarz, J. Huang, D. Chen, Z.-G. Jin, B. F. Boyce, et al.
VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism
J. Biol. Chem., May 9, 2008; 283(19): 13491 - 13499.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Beyer and M. Meyer-Hermann
Mechanisms of organogenesis of primary lymphoid follicles
Int. Immunol., April 1, 2008; 20(4): 615 - 623.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Schmeisser, M. Christoph, A. Augstein, R. Marquetant, M. Kasper, R.C. Braun-Dullaeus, and R.H. Strasser
Apoptosis of human macrophages by Flt-4 signaling: Implications for atherosclerotic plaque pathology
Cardiovasc Res, September 1, 2006; 71(4): 774 - 784.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. R. Dana
Corneal Antigen-Presenting Cells: Diversity, Plasticity, and Disguise The Cogan Lecture
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 722 - 727.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.